PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO (Englisch)
- Neue Suche nach: Vargas-Valencia, J. J.
- Neue Suche nach: Sotelo-Guzmá
- Neue Suche nach: n, M.
- Neue Suche nach: Dí
- Neue Suche nach: az-Ponce, H.
- Neue Suche nach: Galindo-Suá
- Neue Suche nach: rez, R. M.
- Neue Suche nach: Muciñ
- Neue Suche nach: o-Ortega, E.
- Neue Suche nach: Mould-Quevedo, J. F.
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO
-
Autor / Urheber:
-
Erschienen in:VALUE IN HEALTH ; 14 ; 7 ; A559
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A559
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
-
Exportieren:
-
Teilen:
-
Zitieren:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A234
-
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation ModelAlam, M. / Briggs, A. | 2011
- A235
-
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National DataErdogan-Ciftci, E. / Koopmanschap, M. A. | 2011
- A236
-
PR3 Industry Preparedness against German reformsDevienne, E. / White, R. / Mukku, S. | 2011
- A237
-
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness ModellingSaramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. | 2011
- A238
-
UT1 Combining DCE and TTO Into A Single Value FunctionVan Hout, B. A. / Oppe, M. | 2011
- A239
-
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of informationSoini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. | 2011
- A241
-
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European CountriesKay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. | 2011
- A242
-
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel CompoundsAnnemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. | 2011
- A243
-
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In EuropeCerri, K. / Ferná / ndez, J. L. / Knapp, M. | 2011
- A244
-
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in DevelopmentHaakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. | 2011
- A247
-
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in DystoniaPr Coubes, P. / Fluck, L. / Topouchian, A. | 2011
- A248
-
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in SpainFerreira-Gonzá / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
- A249
-
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal OriginCastell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ramó / n, E. / Tellado, J. M. | 2011
- A250
-
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in FranceDe jong, L. / Lafuma, A. / Clé / ment, O. / Aguade, A. S. / Berdeaux, G. | 2011
- A251
-
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile NeutropaeniaShabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. | 2011
- A253
-
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury PatientsBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. | 2011
- A254
-
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot StudyLloyd, A. J. / Herdman, M. / Gonzalez, P. | 2011
- A255
-
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial InfarctionBä / umler, M. | 2011
- A257
-
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care EnvironmentVisnansky, M. / Mesaros, S. | 2011
- A258
-
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient DatabaseHargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. | 2011
- A259
-
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder SymptomsMargolis, M. K. / Coyne, K. / Jumadilova, Z. | 2011
- A260
-
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical OutcomesSmith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. | 2011
- A261
-
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in GermanyAlvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. | 2011
- A262
-
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and BelgiumSennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. | 2011
- A263
-
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of TreatmentsPayakachat, N. / Suen, J. Y. | 2011
- A264
-
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric BypassMar, J. / Arrospide, A. / Mar, B. / Martinez de Aragó / n, G. / Karlsson, J. | 2011
- A265
-
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and EfavirenzVerheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. | 2011
- A266
-
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. | 2011
- A267
-
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 YearsBricout, H. / Maier, W. / Mouchet, J. | 2011
- A268
-
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. | 2011
- A269
-
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health AdministrationChan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. | 2011
- A270
-
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in UgandaKuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. | 2011
- A271
-
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World DataDelissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. | 2011
- A272
-
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral DrugsMiller-Jansö / n, H. E. / Stander, M. | 2011
- A274
-
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in PolandMacioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. | 2011
- A275
-
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)Pepe, C. / Teich, V. / Mould, J. F. | 2011
- A276
-
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in PanamaLutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. | 2011
- A277
-
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in RussiaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. | 2011
- A278
-
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UKThuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. | 2011
- A279
-
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the NetherlandsMeijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. | 2011
- A280
-
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in PolandKawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. | 2011
- A282
-
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B PatientsHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. | 2011
- A283
-
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of PertussisRozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. | 2011
- A284
-
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in ThailandLayton, M. R. / Pachanee, K. / Prakongsai, P. | 2011
- A285
-
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A VaccineFaure, C. / Koller, A. / Hartmann, K. / Chré / tin, S. / Doux, S. / Visè / le, N. / Bugnard, F. / Maier, W. | 2011
- A286
-
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished DataBallesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. | 2011
- A287
-
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve WeeksSapin, C. / Corson, H. / Beillat, M. / Hansen, K. | 2011
- A288
-
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral OlanzapineNovick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. | 2011
- A289
-
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care SystemFaluta, T. / Rdzanek, M. / Pierzgalska, K. / Wró / bel, B. | 2011
- A290
-
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian EmployersReis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. | 2011
- A291
-
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant TherapyAydemir, O. / Dilbaz, N. / Malhan, S. | 2011
- A292
-
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in NorwayEinarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. | 2011
- A293
-
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in AustraliaO'Leary, B. A. / Hamann, G. B. / Adena, M. A. | 2011
- A294
-
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. | 2011
- A295
-
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard ApproachCiesla, J. / Mazurek, K. | 2011
- A296
-
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie DataRabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. | 2011
- A297
-
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and ItalySikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. | 2011
- A298
-
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United StatesChen, Y. J. / Sankaranarayanan, J. / Murman, D. L. | 2011
- A300
-
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in IndiaNagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. | 2011
- A301
-
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castejó / n, N. | 2011
- A303
-
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the ElderlySebestyé / n, A. / Sá / ndor, J. / Patzai, B. / Gõ / cze, K. / Kriszbacher, I. / Mintá / l, T. et al. | 2011
- A304
-
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured PopulationSchabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. | 2011
- A305
-
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech RepublicPetrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. | 2011
- A307
-
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United KingdomPericleous, L. / Lebmeier, M. | 2011
- A308
-
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in ColombiaFernandes, R. A. / Tovar, D. A. / Mould, J. F. | 2011
- A309
-
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in AustraliaTilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. | 2011
- A310
-
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in SpainVilloro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. | 2011
- A311
-
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid ArthritisAdams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. | 2011
- A312
-
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological TherapyGulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / Pé / ntek, M. | 2011
- A314
-
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative StudyWilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. | 2011
- A315
-
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated DuloxetineChen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. | 2011
- A316
-
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention StudyWickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. | 2011
- A317
-
PND3 Risk-Benefit Analysis of Therapy in Multiple SclerosisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. | 2011
- A318
-
PND9 The Role of Spontaneous Events Databases for Benefit-Risk AnalysisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. | 2011
- A319
-
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along SpainRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Espada-Sá / enz-Torre, M. / Tellerí / a-Orriols, J. J. et al. | 2011
- A320
-
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In GreeceAthanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. | 2011
- A321
-
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in FranceFagnani, F. / Kusnik-Joinville, O. / de Zé / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. | 2011
- A322
-
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) DeficiencyTilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. | 2011
- A323
-
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III TrialO' / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. | 2011
- A324
-
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. | 2011
- A325
-
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. | 2011
- A326
-
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple SclerosisKhalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. | 2011
- A327
-
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic ReviewMarfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. | 2011
- A328
-
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United StatesPalmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. | 2011
- A329
-
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. | 2011
- A330
-
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to PlaceboSnedecor, S. J. | 2011
- A331
-
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)Medina Gó / mez, J. L. | 2011
- A332
-
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United StatesAggarwal, S. | 2011
- A333
-
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice ExperimentBaji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. | 2011
- A334
-
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate ProgramDegrassat-Thé / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sinè / gre, M. | 2011
- A335
-
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan IndicationsWild, L. / Forster, L. | 2011
- A336
-
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and ScaleVarol, N. / Costa-i-Font, J. / Mcguire, A. J. | 2011
- A337
-
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement reviewFaulkner, E. C. / Fernandez, M. / Spinner, D. S. | 2011
- A338
-
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature ReviewKarray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. | 2011
- A339
-
PHP37 Regional Drug Evaluation in Spain: A Comparison Among CommitteesHerná / ndez-Pastor, L. J. / Huerta, A. | 2011
- A340
-
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring CountryKrehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. | 2011
- A341
-
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU CountriesPogorilic, S. / Vitezica, P. / Bolanca, S. | 2011
- A342
-
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid EnrolleesGanduglia, C. / Franzini, L. / Dunn, K. | 2011
- A343
-
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased AdherenceHicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. | 2011
- A344
-
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality ImprovementEichler, K. / Senn, O. / Rü / themann, I. / Bö / gli, K. / Sidler, P. / Brü / gger, U. | 2011
- A345
-
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?Comberiati, U. / Dass, R. N. / White, N. | 2011
- A346
-
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA StudyGarrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. | 2011
- A347
-
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. | 2011
- A348
-
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health SystemRebollo, P. / Castejó / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. | 2011
- A349
-
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology DrugsOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. | 2011
- A350
-
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) DepartmentsLaokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. | 2011
- A351
-
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes StrategyAggarwal, S. | 2011
- A352
-
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?Simoens, S. | 2011
- A353
-
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community HospitalsRoh, C. Y. / Shirore, R. M. | 2011
- A354
-
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement SolutionKim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. | 2011
- A355
-
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four ContinentsSchwarzer, R. / Rochau, U. / Mü / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
- A356
-
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative StudyHislop, J. M. | 2011
- A357
-
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical StudentsHettihewa, L. M. / Wimalasena, G. / Tharanga, D. | 2011
- A359
-
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and ManufacturersCarlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. | 2011
- A360
-
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care WorkersFerrario, A. / Nicod, E. / Kanavos, P. | 2011
- A361
-
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the GoalpostsRoberts, G. | 2011
- A363
-
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology AdoptionJena, A. B. / Philipson, T. J. | 2011
- A364
-
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled TrialsCorrales-Á / lvarez, I. / Catalá / pez, F. / Martí / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. | 2011
- A366
-
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular DiseaseAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. | 2011
- A367
-
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive PatientsAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. | 2011
- A368
-
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United KingdomJones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. | 2011
- A370
-
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial InfarctionAhmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbjö / rnsdottir, S. / Steen carlsson, K. | 2011
- A371
-
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in SpainDarba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. | 2011
- A372
-
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial FibrillationBaser, O. / Wang, L. | 2011
- A373
-
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
- A376
-
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in GermanyTheidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. | 2011
- A377
-
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. | 2011
- A378
-
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian AnalysisMittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. | 2011
- A379
-
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato TrialGarcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellströ / m, C. | 2011
- A380
-
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral ArteryRamos-Goñ / i, J. M. / Mar-Medina, J. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. | 2011
- A382
-
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence SurveyHudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. | 2011
- A383
-
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available PatientsVilla, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. | 2011
- A384
-
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction SurveyOberdiek, A. / Sandberg, A. / Franczok, E. | 2011
- A386
-
PCV123 The Participation Decision for Lifestyle Disease ScreeningSø / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. | 2011
- A387
-
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation ServiceRose, P. / James, R. / Chapman, O. / Marshall, S. | 2011
- A388
-
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims DatabaseMolife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. | 2011
- A389
-
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in BrazilNasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. | 2011
- A391
-
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver ToxicityGokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. | 2011
- A392
-
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United StatesJensen, I. S. / Helm, T. / Cyr, P. L. | 2011
- A393
-
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in BelgiumLeeuwenkamp, O. / Chevalier, P. / Lamotte, M. | 2011
- A394
-
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS SettingAreias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. | 2011
- A395
-
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. | 2011
- A396
-
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX MesalamineSolomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. | 2011
- A397
-
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative ColitisStark, R. G. / Hunger, M. F. / Reitmeir, P. / Kö / nig, H. H. / Leidl, R. | 2011
- A398
-
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special PopulationsPaes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. | 2011
- A399
-
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other TreatmentsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. | 2011
- A400
-
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control StudyPockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. | 2011
- A401
-
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and AdolescentsSikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. | 2011
- A402
-
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for ArgentinaEllis, A. / Lepetic, A. C. / Gomez, J. A. | 2011
- A403
-
PIH34 Patient Reported Reasons for Medication Nonadherence: A SurveyLee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. | 2011
- A405
-
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes StudyCarroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. | 2011
- A406
-
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. | 2011
- A408
-
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European CountriesPeev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. | 2011
- A409
-
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological SurveyLoftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. | 2011
- A410
-
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-AnalysisFan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. | 2011
- A412
-
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. | 2011
- A413
-
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French ResultsAmoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. | 2011
- A414
-
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?Pereira, J. / Ribeiro, V. / Mateus, C. | 2011
- A415
-
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in IrelandObradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. | 2011
- A416
-
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary CareAra, R. / Blake, L. | 2011
- A417
-
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice ExperimentMü / hlbacher, A. / Ezernieks, J. / Nü / bling, M. | 2011
- A418
-
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A PatientsJo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. | 2011
- A419
-
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss PharmacotherapyAgatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. | 2011
- A420
-
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic PainRejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. | 2011
- A421
-
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate CancerAggarwal, S. | 2011
- A422
-
PRM11 Learning Effect in Economic Evaluations of Health Care InterventionsChang, S. / Sungher, D. / Diamantopoulos, A. | 2011
- A423
-
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYsCunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garcí / a, C. / Ferrer, M. | 2011
- A424
-
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained ResourcesJahn, B. / Rochau, U. / Mü / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. | 2011
- A425
-
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins MethodsSantos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. | 2011
- A426
-
PRM33 Systematic Review of Health State Utilities in SpainGarcí / a-Pé / rez, L. / Aguiar-Ibá / ez, R. / Linertová / R. / Rivero-Santana, A. / Abá / solo-Alessó et al. | 2011
- A428
-
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in RussiaZelenova, O. | 2011
- A429
-
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated EndpointsAballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. | 2011
- A430
-
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-UpRose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. | 2011
- A431
-
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic DiseaseKarweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. | 2011
- A432
-
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) MeasuresVerjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. | 2011
- A433
-
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. | 2011
- A434
-
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma PatientsZhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. | 2011
- A435
-
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated CohortDarba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. | 2011
- A437
-
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex TrialPacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. | 2011
- A438
-
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data AnalysisClark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. | 2011
- A439
-
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in ItalyDuran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. | 2011
- A440
-
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) PopulationGanguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. | 2011
- A442
-
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims DatabaseRamsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. | 2011
- A443
-
PCN55 The Economic Burden of Adjuvant Chemotherapy in GermanyEiermann, W. / Rezai, M. / Kuemmel, S. / Kü / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. | 2011
- A444
-
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow RegionShakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. | 2011
- A445
-
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in CanadaCasciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. | 2011
- A446
-
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United KingdomSamyshkin, Y. / Hertel, N. / Griebsch, I. | 2011
- A447
-
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in TurkeyBakir, M. / Levent, A. / Nagy, L. / Brandtmü / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. | 2011
- A448
-
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)Arreola Ornelas, H. / Rosado Buzzo, A. / Garcí / a, L. / Camacho, L. M. / Lechuga, D. | 2011
- A449
-
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in PolandGadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. | 2011
- A450
-
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in RussiaTikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. | 2011
- A452
-
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European CountriesRetsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. | 2011
- A453
-
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung CancerZaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. | 2011
- A455
-
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European StudyGunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. | 2011
- A456
-
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in MalaysiaFarooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. | 2011
- A457
-
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel TherapyJames, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. | 2011
- A458
-
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer TherapyAn, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. | 2011
- A459
-
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final ResultsArtal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodrí / guez-Abreu, D. / Menendez-ureñ / a, M. / Andrade, J. et al. | 2011
- A461
-
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped UtilitiesBatty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. | 2011
- A462
-
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi StudySkroumpelos, A. / Pavi, E. / Kyriopoulos, J. | 2011
- A463
-
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily PracticeBlommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. | 2011
- A464
-
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in EuropeBresse, X. / Largeron, N. / Marty, R. / Roze, S. | 2011
- A465
-
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in EnglandViejo Viejo, I. / Kilby, S. | 2011
- A466
-
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN GuidelinesVitezic, D. / Vrdoljak, E. / Bolanca, S. | 2011
- A467
-
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell CarcinomaDe groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. | 2011
- A468
-
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009Kellermann, L. / Hofheinz, R. D. / Arnold, D. | 2011
- A469
-
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal CancerTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. | 2011
- A471
-
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based StudyHolstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. | 2011
- A472
-
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or LiraglutideScott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. | 2011
- A473
-
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)Gottesman, I. / Girard, M. / Shorey, S. | 2011
- A474
-
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use ConditionsTaieb, C. / Auges, M. | 2011
- A475
-
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in ItalyIannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. | 2011
- A476
-
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in BulgariaBoyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. | 2011
- A477
-
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK SettingMcDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. | 2011
- A478
-
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. | 2011
- A479
-
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal SettingsCarvalho, D. / Lindner, L. / Kozarzewski, M. | 2011
- A480
-
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based AnalysisPatel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. | 2011
- A482
-
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes MellitusMoreira, S. / Almeida, A. / Guerra, P. | 2011
- A483
-
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) DatabaseAargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. | 2011
- A484
-
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. | 2011
- A485
-
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes PatientsAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. | 2011
- A486
-
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 DiabetesNagy, B. / Nagyjanosi, L. / Nagyistok, S. / Jó / zwiak-Hagymá / sy, J. / Dessewffy, Z. / Kalo, Z. / Vokó / Z. | 2011
- A487
-
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc StudyLeiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Españ / a, F. / Garcí / a-Ruiz, A. / Prados-Torres, D. | 2011
- A488
-
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic RhinoconjunctivitisRonborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. | 2011
- A489
-
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) PerspectiveSuzuki, C. / Silva, N. L. | 2011
- A490
-
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 YearsJansson, S. A. / Backman, H. / Lindberg, A. / Rö / nmark, E. / Lundbä / ck, B. | 2011
- A492
-
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in AustraliaTilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. | 2011
- A493
-
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK SettingPaggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. | 2011
- A494
-
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. | 2011
- A495
-
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary DiseaseAtsou, K. / Hejblum, G. / Chouaid, C. | 2011
- A496
-
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. | 2011
- A497
-
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary DiseaseLeidy, N. / McCormack, J. / Hamilton, A. / Becker, K. | 2011
- A498
-
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary DiseaseAgh, T. / Inotai, A. / Meszaros, A. | 2011
- A499
-
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to FluoroquinolonesSimoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. | 2011
- A500
-
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. | 2011
- A501
-
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture ModelsStull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. | 2011
- A502
-
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational StudyGerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. | 2011
- A503
-
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic EvaluationMartinez Ferez, I. M. / Flores Moreno, S. | 2011
- A504
-
PSS16 Cost of Blindness in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. | 2011
- A505
-
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsPadula, W. V. / Yilmaz, T. / Cordero-Coma, M. | 2011
- A506
-
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration ModelsVisser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. | 2011
- A507
-
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity GroupsAcaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. | 2011
- A508
-
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
- A509
-
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With PsoriasisTabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. | 2011
- A511
-
ISPOR 14th annual European congress financial disclosure information for research presetnations| 2011
- A521
-
ISPOR 14th Annual European Congress Research Abstracts Author Index| 2011
- A535
-
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corrê / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. | 2011
- A536
-
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En ColombiaAlfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. | 2011
- A537
-
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En ColombiaRico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. | 2011
- A538
-
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion MedicaQuintana Carrillo, R. / Arrieta Rodrí / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. | 2011
- A539
-
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in BelizeHeredia Pi, I. B. / Pé / rez Nú / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. | 2011
- A540
-
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. | 2011
- A541
-
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos NeonatalesReyes-Lopez, A. | 2011
- A542
-
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En ColombiaRuiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. | 2011
- A543
-
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic PainGalindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. | 2011
- A544
-
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El ImssGonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Herná / ndez, I. C. / Abbo, M. C. | 2011
- A545
-
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La HipertrigliceridemiaRendon, D. / Ordoñ / ez, J. / Orozco, J. J. | 2011
- A546
-
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in MexicoZanela, O. O. / Cabra, H. A. / Muñ / oz, D. F. | 2011
- A547
-
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in MexicoCarlos, F. / Ramí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. / Ramos, E. | 2011
- A548
-
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)Hé / buterne, X. / Lé / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. | 2011
- A549
-
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su CreaciónRivera-Peñ / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. | 2011
- A551
-
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los CostosMino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. | 2011
- A552
-
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇaPais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. | 2011
- A553
-
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, GhanaAgyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. | 2011
- A554
-
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and PolandKirpekar, S. / Shankland, B. | 2011
- A555
-
PHP41 Monitoring of HPV Vaccination Effectiveness Within European UnionBielik, J. / Maruš / ková / E. / Glogowski, C. | 2011
- A556
-
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticosMota, D. M. / Araú / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
- A558
-
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010Gutierrez-Delgado, C. / Gó / mez-Fraga, S. | 2011
- A559
-
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)Morales Buenrostro, L. E. | 2011
- A560
-
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In SwedenPudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. | 2011
- A561
-
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro socialClark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. | 2011
- A562
-
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in GuatemalaLutz, M. / Cuesta, G. / Morales, G. | 2011
- A563
-
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in BrazilTeich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. | 2011
- A565
-
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term PatientsMayen-Herrera, E. / Buesch, K. / Cortina, D. | 2011
- A566
-
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009Heredia, I. / Servá / n, E. / Reynales, L. M. / Bautista, S. | 2011
- A567
-
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. | 2011
- A568
-
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In MexicoArocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. | 2011
- A569
-
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or HemodialysisMayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. | 2011
- A571
-
ISPOR 3rd Latin America conference disclosure information for reserch presentations| 2011
- A573
-
ISPOR 3rd Latin America Conference Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
- I
-
Instructions for Authors| 2011
-
PCN2 A Retrospective Longitudinal Study of Treatment Patterns and Outcomes Among Patients with Unresectable Stage IIIc/IV Melanoma in Canada (Melody)Osenenko, K. / Szabo, S. M. / Schultz, M. / Mihalcioiu, C. / Lane, S. / Levy, A. R. | 2011
-
PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in SpainWalter, E. / Brennig, C. / Schö / llbauer, V. | 2011
-
PCN143 Electronic Patient-Reported Outcome Monitoring in Testicular Cancer PatientsGiesinger, J. M. / Oberguggenberger, A. / Kemmler, G. / Gamper, E. / Steiner, H. / Sztankay, M. / Holzner, B. | 2011
-
PDB58 How Much Do Patients with Type 2 Diabetes Value Improvements in Dosing Convenience? Results from a Conjoint StudyHauber, A. B. / Han, S. / Yang, J. C. / Gantz, I. / Tunceli, K. / Gonzalez, J. M. / Brodovicz, K. / Alexander, C. / Davies, M. / Lento, K. | 2011
-
PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish RegionsDarba, J. / Kaskens, L. | 2011
-
PDB11 Glycemic Outcomes Among Patients Receiving Exenatide BID or Liraglutide for Type 2 Diabetes in Clinical Practice: A Retrospective Analysis of the GE Centricity EMR DataBest, J. H. / Wintle, M. / Saunders, W. B. / DeYoung, M. B. / Blickensderfer, A. / Maggs, D. | 2011
-
PHP9 Preditores Da quantidade De Medicamentos Tomados Em Pessoas Com DoenÇa CrónicaPais-ribeiro, J. / Silva, I. / Meneses, R. / Pedro, L. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Vilhena, E. / Mendonç et al. | 2011
-
PIH5 Replacing MMR By MMRV in Mexico: Assessement of Cost-Effectiveness Based on a Dynamic Transmission ModelOuwens, M. / Macias, M. / Mascareñ / as De Los Santos, A. H. / Gomez, J. A. / Sauboin, C. / Carreñ / o Manjarrez, R. | 2011
-
PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Doering, C. / Augustin, M. | 2011
-
PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) TreatmentsBridges, J. F. / Mohamed, A. / Finnern, H. W. / Hauber, A. B. / Woehl, A. | 2011
-
PRS26 Direct Costs of Pneumonia in the United States: An Analysis of 2008 Medical Expenditure Panel Survey (MEPS) DataParkv, H. / Rascati, K. L. | 2011
-
PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch SettingStern, S. / van Nooten, F. / Groot, M. / Brown, R. | 2011
-
PRS43 Pharmacoeconomic Evaluation of Antibiotic Therapy of Community-Acquired Infections of the Lower Respiratory Tracts By the Use of Moxifloxacin Versus Clarithromycin in UkraineMishchenko, O. / Iakovlieva, L. / Matyashova, N. | 2011
-
PSS2 Prevalence, Demographics and Treatment Characteristics of Visual Impairment Due to Diabetic Macular Edema in A Representative Canadian CohortPetrella, R. J. / Blouin, J. / Davies, B. / Barbeau, M. | 2011
-
PSS15 Burden of Chronic Tinnitus in HungaryKiss, Z. | 2011
-
PSS41 Impact on Quality of Patients With Active and Inactive Psoriasis in SpainDauden, E. / Herrera, E. / Puig, L. / Sá / nchez-Carazo, J. L. / Toribio, J. / Caloto, M. T. / Nocea, G. | 2011
-
PCN6 Evaluacion Economica Del Dasatinib En El Tratamiento De La Leucemia Mieloide Cronica En Pacientes Resistentes Al Imatinib En ChileOrozco, J. J. / Valencia, J. E. / Aiello, E. / Caputo, M. | 2011
-
PSS38 3-D Study - Description of the Care of the Dental PainWierzba, C. / Auges, M. / Watt, M. / Taieb, C. | 2011
-
PCN126 Which Factors Can Affect Utilities?Kang, E. / Lee, J. / Jeong, H. | 2011
-
PMD52 Workload in German Hospitals Caused by Routine Follow-up Services for Cardiac Implantable Electrical Devices (CIED)Smala, A. / Vogtmann, T. | 2011
-
PND6 Outcomes of Antiepileptic Drugs Uses at Doses Above the Recommended Range Among Children with Structural-Metabolic Epilepsy in MalaysiaSalih, M. / Bahari, M. B. / Hassali, M. A. / Shafie, A. A. / Al-lela, O. Q. / Abd, A. Y. / Ganesan, V. | 2011
-
PND64 Cost-Minimization Analysis of IFNB-1B and Fingolimod among Multiple Sclerosis Patients in GermanyPan, F. / Goh, J. / Wang, C. / Meinhardt, M. | 2011
-
PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in GreeceManiadakis, N. / Boumpas, D. / Kourlaba, G. / Christou, P. / Anargiros, I. / Smets, E. / Purcaru, O. | 2011
-
PMS40 Economic Evaluation of Etanercept in Rheumatoid Arthritis from the Public Payer perspective in BrazilFernandes, R. A. / Takemoto, M. L. / Tolentino, A. C. / Takemoto, M. M. / Santos, P. M. / Mould, J. F. | 2011
-
PND21 Cost of Alzheimer'S Disease in RomaniaPaveliu, M. S. / Tudose, C. / Tudose, F. | 2011
-
PMH69 Deprivation and Use of Atipycal Antipsychotics in SchizophreniaMoisan, J. / Lauzier, S. / Vanasse, A. / Lesage, A. / Courteau, J. / Fleury, M. J. / Gregoire, J. P. | 2011
-
PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia PatientsKim, B. R. / Lee, T. J. / Woo, J. M. / Park, J. I. / Kwon, J. S. | 2011
-
PMH53 Follow-up of Health-Related Quality of Life in Young Heroin UsersCatalà / L. / Ferrer, M. / Sanchez-Niubò / A. / Brugal, M. T. / Domingo-Salvany, A. / Itinere, I. | 2011
-
PMH68 Differential Use of Extended and Instant Release Quetiapine: A Naturalistic Study of Finnish Inpatients with Schizophrenia Spectrum or Bipolar DisordersHallinen, T. / Soini, E. J. / Granströ / m, O. / Ovaskainen, Y. / Leinonen, E. / Koponen, H. J. / Hä / nninen, K. | 2011
-
PMS32 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in VenezuelaFernandes, R. A. / Boada, V. / Mould, J. F. | 2011
-
PCV94 Dronedarone is Cost-Effective for the Prevention of Downstream Cardiovascular Morbidity and Mortality in Australian Patients with Atrial FibrillationLiew, D. / Lee, J. / Gonzalo, F. | 2011
-
PHP99 Reimbursing Telemonitoring in Europe: Are Payers Ready?Flostrand, S. / Garde, E. / Toumi, M. | 2011
-
PGI30 Comparison of Health Related Quality of Life Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma: Results of the Come StudyCiampichini, R. | 2011
-
PCV143 Implementation of Evidence-Based National Guidance on Venous Thrombo-Embolism Prophylaxis for Hospital Inpatients in EnglandGericke, C. A. / Boiko, O. / Child, S. / Nokes, T. / Copplestone, A. / Sheaff, R. | 2011
-
PCN68 Cost-Effectiveness and Quality of Life Analysis of the Multicenter Itac02-01 Study: Prospective Randomized Comparison of Reduced Intensity Versus Non-Myeloablative Conditioning Regimen for Matched Related Allogeneic Stem Cell TransplantationLe Corroller Soriano, A. G. / Siani, C. / Tabrizi, R. / Michallet, M. / Bay, J. O. / Fabre, R. / Boher, J. M. / Blaise, D. | 2011
-
PIH37 The Royal Road or the Middle Way? Public and Patient Preferences for Health OutcomesVersteegh, M. / Brouwer, W. | 2011
-
PCV1 Costs, Length of Stay and ALL-Cause Mortality in Ruptured Versus Unruptured Cerebral Aneurysm Among Inpatients in the United StatesWallace, K. L. / Hashemi, L. / Minshall, M. E. | 2011
-
PHP11 The Use of Methylphenidate in A Group of Patients with Attention Deficit and Hyperactivity DisorderGomez-galicia, D. L. / Rodriguez-fragoso, L. / Lopez aymes, G. / Sá / nchez-Alemá / n, M. / Reyes-esparza, J. A. | 2011
-
PHP46 PrÁctica Clínica Institucional En El Tratamiento De La Diabetes Mellitus Tipo 2 En MÉxicoJuarez-Garcia, A. / Vargas-Valencia, J. / Martinez-Rivera, G. / Sotelo-Guzmá / n, M. / Elias-Ló / pez, J. I. / Zamora-Barron, M. / Rangel, S. | 2011
-
PCN5 Reduced Risk of Chemotherapy-Induced Nausea and Vomiting in Patients with Cancer Treated with Highly Emetogenic Chemotherapy and Antiemetic Prophylaxis With PalonosetronSchwartzberg, L. / Jackson, J. / Jain, G. / Balu, S. | 2011
-
PIH7 The Efficiency of in Vitro Fertilization in Hungary 2000-2010Gresz, M. / Varga, S. / Boncfö / ldi, K. / Sebestyé / n, A. / Kriszbacher, I. / Boncz, I. | 2011
-
PCN36 The Economic Impact of Treating Early Lung Cancer: A Systematic ReviewMahar, A. L. / Fong, R. / Johnson, A. | 2011
-
PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in PortugalDarba, J. / Kaskens, L. / Abecasis, M. / Vitorino, R. / Carrasco, J. | 2011
-
PCV108 Deriving Utility Values from the General Population for Dronedarone in the Treatment of Atrial FibrillationAdams, J. / Lee, J. / Gonzalo, F. | 2011
-
PMD56 A Systematic Literature review on the Clinical and Economic outcomes attributable to the Use of Hemostatic Matrix during Tonsillectomy and AdenoidectomyWilliams, E. N. / Kreuwel, H. / Krishnan, S. | 2011
-
PSU12 Estimating Cost and Resource Use for Whole Brain Radiation Versus Stereotactic Radiosurgery Treatments Among Brain Metastasis PatientsGanguli, A. / Dacosta Byfield, S. / Teitelbaum, A. / Ray, S. | 2011
-
HG1 Applying Frailty Model in Longitudinal Survivals of Chronic DiseasesLi, Y. / Holtzer-Goor, K. / Uyl-de Groot, C. / Al, M. | 2011
-
PIN44 Cost-Effectiveness of Quadrivalent HPV Vaccination in Germany Using A Dynamic Transmission ModelSchobert, D. / Remy, V. / Schö / ffski, O. | 2011
-
PMD22 Economic Evaluation of Amino-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) Test in Patients with Dyspnea attending to Emergency Department (ED) in SpainLlorens, P. / Moreu, J. / Rodrí / guez, J. / Pé / rez Alcá / ntara, F. | 2011
-
PIN106 HIV Screening Programme in Community Pharmacies of the Basque CountryGorostiza, I. / Elizondo, I. / Braceras, L. | 2011
-
PMD68 Purchasing and Adopting Cardiovascular Devices: A Global SurveyMenzin, J. / Neumann, P. / Duczakowski, C. / Woodward, R. M. / Friedman, M. / Outlaw, J. J. / Durtschi, A. | 2011
-
PND4 A Meta-analysis of the Duration of Clinical Effect of onabotulinumtoxina in Cervical DystoniaMarsh, W. / Monroe, D. / Gallagher, C. | 2011
-
PHP52 Inequalities in the Utilization of Home Hospice Services in HungaryTurcsanyi, K. / Domjá / n, P. / Pakai, A. / Gombos, G. / goston, I. / Vas, G. / Molics, B. / liá / s, Z. et al. | 2011
-
PHP71 Effect of SIADH on Patient outcomes and Health Care Resource Utilization in Hospitalized PatientsAmin, A. / Deitelzweig, S. / Lin, J. / Christian, R. / Baumer, D. / Lowe, T. | 2011
-
PIH25 Cost-Effectiveness of Interventions Against Childhood ObesityRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. | 2011
-
PIH10 Examination of Female Balance Maintenance Ability in Major Life StagesHock, M. / Dakos, Z. / Dá / lnoki, x. / Hajnal, B. / Krá / nicz, J. / Kriszbacher, I. / Boncz, I. / Bó et al. | 2011
-
PSY19 Economic Costs of Chemotherapy-Induced Febrile Neutropenia Among Patients with Non-Hodgkin'S Lymphoma in European Clinical PracticeWeycker, D. / Danel, A. / Marciniak, A. / Bendall, K. / Lipsitz, M. / Pettengell, R. | 2011
-
PSY24 Pregabalin is Cost-Saving in Comparison with Gabapentin Treated Patients when Added to Existing Therapy in the Management of Painful RadiculopathiesSicras-Mainar, A. / Navarro-Artieda, R. / Planas, A. / Ruiz, L. / Rejas, J. | 2011
-
PSY29 Economic Evaluation of Capsaicin Patch 8% in the Treatment of Neuropathic Pain in AustriaBrennig, C. / Walter, E. / Schö / llbauer, V. | 2011
-
PSY54 A Cost Estimation of the New Guideline to Treat Bleeding Episodes in Patients with Haemophilia and Inhibitors in IranJaberidoost, M. / Abdollahiasl, A. / Nikfar, S. / Khatibi, M. | 2011
-
PIH16 analyzing the Adverse Drug reactions of Geriatric Population at A regional Academic Hospital of southern TaiwanLin, P. T. / Cheng, Y. D. | 2011
-
PIH40 Designing a Disease-Specific Patient Reported Outcome (PRO) for a Rare Disease: Assessing the Reliability, Validity, and Responsiveness of the Hunter Syndrome - Functional Outcomes for Clinical Understanding Scale (HS-Focus)Wiklund, I. / Raluy, M. / Jangelind, Y. / Whiteman, D. A. / Conway, A. M. / Pang, F. / Stull, D. E. / Chen, W. H. | 2011
-
PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus PregabalinZhao, Y. / Sun, P. / Sun, S. | 2011
-
PHP91 Patient Safety Activities Associated with Hospital Pharmacy in A Nationwide Survey on Management System for Patient SafetyHirose, M. / Imanaka, Y. | 2011
-
PHP102 Biosimilars: Pricing & Reimbursement in Germany: Key Insights From Sickness FundsChaudhari, S. D. / Bache, B. | 2011
-
PHP106 when is Lower Level Evidence of Effectiveness Acceptable in Reimbursement Decisions?: A Decision Algorithm to Guide Policy Makersde Groot, S. / Rijnsburger, A. / Heymans, J. / Redekop, W. | 2011
-
PHP121 The Role of Molecular Tests in Shaping Comparative Effectiveness Review (CER)Hughes, K. E. / Williams, R. | 2011
-
PCV34 Improving Global Vascular Risk Management (GVRM) Using the COSEHC Cardiovascular Risk Assessment ToolFerrario, C. / Moore, M. / Simmons, D. / Colby, C. / Exuzides, A. / Panjabi, S. | 2011
-
PHP22 Use of Decision Modeling to Estimate the Negative Impact of Tobacco Use on Health Care Costs and Health Disparities in People Living with HIVBurbano-Levy, X. / Miguez, M. J. / Thompson, M. / Medina, A. / Quiros, C. / Malow, R. | 2011
-
PRM4 A MIXED-Effects Piecewise Linear Model Of The Rate Of Lung Function Decline Before And After Inhaled Corticosteroids In An Observational Study Of Children With Cystic FIBROSISPasta, D. J. / Rasouliyan, L. | 2011
-
PCN93 Cost-Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic ReviewBongers, M. L. / Coupe, V. M. / Jansma, E. P. / Smit, E. F. / Uyl-de Groot, C. | 2011
-
PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand EczemaCortesi, P. A. / Scalone, L. / De Pità / O. / Angelini, G. / Cristaudo, A. / Girolomoni, G. / Gola, M. / Ayala, F. / Cannavò et al. | 2011
-
PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer TreatmentsBeauchemin, C. / Cooper, D. / Lachaine, J. | 2011
-
PRS8 Cost-Effectiveness of an Ambulatory program of Pulmonary rehabilitation following Acute Exacerbations of Copd in ColombiaGiraldo, L. F. / Brito, K. P. / Rodriguez, P. | 2011
-
AD3 Assessing The Compliance And Persistence of Allergen Immunotherapy In Allergic Rhinitis Using A Retrospective Pharmacy Database From The NetherlandsKiel, M. A. / Gerth van Wijk, R. / Rö / der, E. / Al, M. J. / Hop, W. C. / Rutten-van Mö / lken, M. P. | 2011
-
PMD3 Biochemical Markers for the Identification of Intracranial Injury Following Minor Head injury: A Systematic Review and Meta-AnalysisPickering, A. / Fitzgerald, P. / Harnan, S. E. / Pandor, A. / Goodacre, S. W. | 2011
-
PUK7 3 Years Follow Up of the Pharmacotherapy Cost of Patients with Kidney Transplantation in BulgariaGeorgieva, S. S. / Stoimenova, A. / Petrova, G. | 2011
-
CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL: A Pooled Analysis Of Individual Patient Data From NCIC Clinical TrialsEdiebah, D. E. / Quinten, C. / Coens, C. / Zikos, E. / Ringash, J. / Gotay, C. / Flechtner, H. H. / Osoba, D. / King, M. / Cleeland, C. | 2011
-
PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal StentsBurgers, L. T. / Redekop, W. / Severens, J. L. | 2011
-
PMD84 Assessing Cost Effectiveness and Value of Further Research When Data are Sparse: Negative Pressure Wound Therapy for Severe Pressure UlcersSoares, M. O. | 2011
-
PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population: A Nice Diagnostic Guidance ProjectBurgers, L. T. / Redekop, W. / Westwood, M. / Lhachimi, S. / Severens, J. L. / Armstrong, N. / Sculpher, M. J. / Walker, S. / Mckenna, C. / Al, M. J. | 2011
-
PSU3 Prevalence Rates of Surgical Complications Among Tuberous Sclerosis Complex Patients with Surgical Removal of Subependymal Giant Cell Astrocytoma: A Real-World National Retrospective Cohort StudySun, P. / Liu, Z. / Rogerio, J. / Guo, A. / Garay, C. / Kohrman, M. | 2011
-
PSU19 the Doors-Study of On-Pump Versus Off-Pump Coronary Artery bypass Grafting: A Post Hoc Analysis of Methods for Multiple Imputation of Missing Data in Economic EvaluationEhlers, L. / Fenger-grø / n, M. / Beck, S. S. / Houlind, K. / Lauridsen, J. | 2011
-
PIN26 Economic and Health Related Quality of Life (HRQL) Comparison of Lopinavir/Ritonavir (LPV/R) and Atazanavir Plus Ritonavir (ATV+RTV)-Based Regimens for Antiretroviral (ARV) Experienced Brazilian Patients in 2011Simpson, K. / Baran, R. / Dietz, B. | 2011
-
HT2 Value Based Pricing: One Threshold too Far for the United KingdomRoberts, G. | 2011
-
PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in SpainBrosa, M. / Barrios, V. / Lobos, J. M. / Serrano, A. / Capel, M. / Alvarez, C. | 2011
-
PCV96 Cost-Utility Analysis of the Long-Term Cardiovascular Prevention Program in Russian Federation as an Argument for the Widespread Introduction of Preventive Technologies Into Clinical PracticeKontsevaya, A. / Kalinina, A. / Deev, A. | 2011
-
PCV119 Relationship Between Quality of Life and Level of Cardiovascular Risk and Comorbidities in Spanish Hipertensive Patients-Alhambra StudyFont, B. / Lahoz, R. / Salazar, J. / Roca-cusachs, A. / Abellá / n, A. | 2011
-
PSY7 Budget Impact Analysis of Bendamustine in the Treatment of Multiple Myeloma in SpainMateos, M. V. / Collar, J. M. | 2011
-
PIN81 Cost-Effectiveness Analysis of Peg-Interferon Alpha-2A Plus Ribavirin Versus Conventional Interferon Alpha-2A Plus Ribavirin for the Treatment of Chronic Hepatitis C in ChinaChen, W. / Wei, L. | 2011
-
PMD8 Systematic Review of the Impact Different Metal Femoral Stems (MFSS) Have on Patient outcomes in total Hip replacement (THR) Due to Osteoarthritis (OA)Edwards, S. J. / Hamilton, V. / Nherera, L. / Arber, M. | 2011
-
PIN89 Do Patients and Physicians Have Similar Preferences Chronic Hepatitis B Treatment Outcomes in Turkey?Mohamed, A. / Johnson, F. R. / Hauber, A. B. / Lescrauwaet, B. / Saylan, M. | 2011
-
PIN91 Sensitivity of Pro's in Evaluating Adverse Events in People Receiving Influenza VaccinationWade, A. / Crawford, G. / Pumford, N. / Mcconnachie, A. | 2011
-
PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and AustraliaBecker, R. V. / Teich, V. / Pepe, C. | 2011
-
PMH70 Economic Impact of Focal Epilepsy in Spain: Results of the Espera StudyVillanueva, V. / Brosa, M. / Doz, M. / Aguade, A. S. / Levy-bachelot, L. / Lahuerta, J. / Herná / ndez-Pastor, L. J. | 2011
-
PMS75 Explanatory Factors for the Rheumatoid Arthritis Patients' Access to Biological Agents in 15 European CountriesLaires, P. A. / Exposto, F. / Barosa, P. / Hormigos, B. / Martins, A. P. | 2011
-
PCV18 Relative Efficacy of Bivalirudin vs. Heparin Alone in STEMI Patients Treated with Primary PCI – an Indirect Treatment ComparisonMedic, G. / Schwenkglenks, M. / Eijgelshoven, I. / Smith, A. / Day, J. / Plent, S. / Bergman, G. / Toward, T. | 2011
-
PCV39 Heparin-Induced Thrombocytopenia Type II in Times of Demographic Changes – Epidemiological and Economic Aspects in GermanySchopohl, D. / Berger, K. / Schramm, W. | 2011
-
PCV68 Pharmacogenomic Testing for Warfarin Use in Typical outpatient Settings Lowers Health Care Costs: The Medco-Mayo Warfarin Effectiveness StudyAubert, R. E. / Epstein, R. S. / Yao, J. / O'Kane, D. J. / Tinnirello, J. / Teagarden, J. R. / Moyer, T. P. | 2011
-
PCV58 the Impact of Comorbid Mental Illness on Costs of Health Care for Inpatients with Heart FailureShimizu, S. / Ishikawa, K. B. / Ito, H. / Fushimi, K. | 2011
-
PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy: A German Statutory Health Insurance PerspectiveGraf von der Schulenburg, J. M. / Weycker, D. / Kaiser, E. / Neidhardt, K. / Brede, Y. | 2011
-
PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease: Cost-Effectiveness in the Dutch PopulationVan Gils, P. F. / Hamberg-van Reenen, H. H. / Over, E. / de Wit, G. A. / van den Berg, M. / Schuit, A. J. / Engelfriet, P. M. | 2011
-
PCN44 Cost-of-Illness Study of Human Papillomavirus Cancers in EnglandTempest, M. J. / Thurston, S. / Carroll, S. / Charman, F. / Rajoriya, F. | 2011
-
PSY10 Budget Impact Analysis of Somatuline Autogel in the Management of Acromegaly in SpainBrosa, M. / Betoret, I. / Tapias, G. | 2011
-
PSY18 Resource Consumption Evaluation for Ketoprophene, Ketorolac, Parecoxib and Tenoxicam at Orthopedic Surgery Post-Operation in Brazilian Patients from Private Payers PerspectiveFujii, R. K. / Mould, J. F. / Lanzara, G. | 2011
-
PCN157 The Impact of a Patient Support Program on Access to Oral Oncology Therapy in the United StatesPashos, C. L. / Cragin, L. S. / Khan, Z. M. | 2011
-
PCN185 A Multi-Country Retrospective Study of Patient Characteristics and Treatment Patterns in Chronic Myeloid LeukemiaMitra, D. / Trask, P. C. / Iyer, S. / Candrilli, S. D. / Kaye, J. A. | 2011
-
PDB63 Anti-Diabetic Therapeutic Strategies for Type 2 Diabetes Patients with Chronic Kidney Disease in FranceAmalric, F. / Attali, C. / Joly, D. / Simon, D. / Verges, B. / Grandfils, N. / Briand, Y. | 2011
-
PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical PracticeEmons, M. F. / Dean, B. / Yu, H. T. / Barber, B. / Malin, J. / Zhao, Z. | 2011
-
PCN11 Bevacizumab in Combination with Chemotherapy for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Beltrá / n, C. | 2011
-
PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry): A “Real Life” Overview of Treatment by Office-Based Oncologists in GermanyHartmann, H. / Knauf, W. / Abenhardt, W. / Aldaoud, A. / Lerchenmü / ller, C. / Koska, M. | 2011
-
PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill PatientsBaser, O. / Wang, L. | 2011
-
PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore TrialKnudsen, M. S. / Thomas, S. / Gallagher, M. / Mitchell, P. | 2011
-
PHP23 La Aceptacion De Las Vacunas En Los programas Nacionales De inmunizacion En Latina America: Un Estudio ComparativoJones, K. | 2011
-
PHP42 Calidad De Vida Relacionada Con La Salud Y Apoyo Social En Estudiantes De Farmacia En VenezuelaParra, G. / Bastardo, Y. | 2011
-
PMS5 analisis De Costo-Efectividad De Agentes Biologicos En El Tratamiento De Pacientes Con Artritis reumatoide Activa Y respuesta insuficiente A Farme Tradicionales Desde La perspectiva Del Sistema Publico De Salud En MéxicoCarlos, F. / Aguirre, A. / Pelá / ez-Ballestas, I. / Ramos, E. | 2011
-
PRM5 Incorporating Equity Into Developing and Implementing Evidence-Based Clinical Practice GuidelinesEslava-Schmalbach, J. H. / Sandoval Vargas, G. / Mosquera, P. A. | 2011
-
PSY3 Use Of A Discrete Event Simulation Model To Estimate Long Term Economic Outcomes Of Bariatric Surgery In Morbidly-Obese, Type-2 Diabetic Patients In MexicoZanela, O. O. / Cabra, H. A. / Anaya, P. / Rodriguez, S. / Melendez, G. / Rupprecht, F. | 2011
-
PMH11 Psychotropic-Related Hip Fractures Around the World: A Meta-AnalysisYoung, J. / Pepper, G. A. / Oderda, L. / Asche, C. V. | 2011
-
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in ThailandSakul-isariyaporn, C. / Lertiendumrong, J. / Vasavid, C. / Pachanee, K. | 2011
-
PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries: Case of Côte d'IvoireDiaby, V. / Lachaine, J. | 2011
-
PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials: Evaluation of Structual Equation Modelling for Assessing EquivalenceNixon, M. / Burgess, A. J. | 2011
-
PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid LeukaemiaHoyle, M. W. | 2011
-
PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in GermanyDiepgen, T. L. / Purwins, S. / Posthumus, J. / Kuessner, D. / Augustin, M. | 2011
-
PRM57 Revisiting HPV Vaccination: Why Existing CEAs Underestimate the Vaccine'S Cost-Effectiveness and Incorrectly Estimate Its Threshold PriceO'Mahony, J. | 2011
-
HS4 Impacto Economico En La Atencion Medica De Enfermedades Asociadas Al Tabaquismo En Una Poblacion MexicanaPé / rez Zincer, F. / Quintana Carrillo, R. / Barrios Nanni, R. / Chagoya Bello, J. / Ramos Reyna, E. / Reynales Shigematsu, L. | 2011
-
PMS2 Osteoporosis Medication Might Help reduce the incidence of Second Hip Fractures?Sebestyé / n, A. / Sá / ndor, J. / Betlehem, J. / Boncz, I. | 2011
-
PCN187 Treatment Patterns in Patients with Metastatic MelanomaZhao, Z. / Wang, S. / Barber, B. / Gao, S. K. / Wagner, V. | 2011
-
PCN63 Cost-Effectiveness of Sunitinib in Patients with Advanced or Metastatic Pancreatic Neuroendocrine Tumors in PortugalSoares, M. / Inê / s, M. / Contente, M. | 2011
-
PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in ScotlandNikoglou, E. / Humphreys, S. / Pellissier, J. / O' Regan, C. | 2011
-
PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational StudyHechmati, G. / Cure, S. / Goué / po, A. / Hoefeler, H. / Lorusso, V. / Lü / ftner, D. / Durá / n, I. et al. | 2011
-
PDB57 Polish Health Care System for Diabetic Patients: The Analysis of Current Health Care System and the Need of Community Pharmacy ImplementationRzeszotarska, O. / Hermanowski, T. R. / Rdzanek, M. | 2011
-
PCN198 Review of Economic Assessments of Emerging Genomic Technologies in OncologyQuecedo, L. / Del Llano, J. | 2011
-
PRS37 The Impact of Regional Data on Cost-Effectiveness Results of Salmeterol/Fluticasone Propionate (SAL/FP) + Fenoterol/Ipratropium Bromide (Fen/IB) Versus Fen/IB Only in COPD TreatmentYagudina, R. / Kulikov, A. / Chuchalin, A. G. / Belevsky, A. / Demko, I. V. / Lomakin, A. / Shchurov, D. | 2011
-
PRS53 Further Developments of the Asthma Life Impact Scale (ALIS)Crawford, S. R. / McKenna, S. / Twiss, J. / Tammaru, M. / Oprandi, N. C. | 2011
-
IN1 Evaluacion De COSTO-Efectividad Con El Uso De Linezolid Para El Tratamiento De Infecciones Complicadas De Piel Y Tejidos BlandosVargas-Valencia, J. J. / Sotelo-Guzmá / n, M. / Dí / az-Ponce, H. / Galindo-Suá / rez, R. M. / Muciñ / o-Ortega, E. / Mould-Quevedo, J. | 2011
-
PIH2 Addressing Childhood Obesity In Mexico: Savings On Health Care Expenditures From Regulating Food And Beverage Sales In Basic Education SchoolsGuajardo-Barron, V. J. / Gutierrez-Delgado, M. C. / Rivera-Peñ / a, G. | 2011
-
PMS1 Meta-analisis De La Efectividad Y Seguridad Del Uso De Celecoxib En El Manejo Del Dolor Cronico vs Otros Cox-2 En Pacientes Con Osteartritis O Artritis reumatoideVargas-Valencia, J. J. / Granados-Soto, V. / Galindo-Suá / rez, R. M. / Mould-Quevedo, J. | 2011
-
PIN20 Clinical and Economical Impact of Pneumococcal Vaccination in Spanish Adult Population Measured by a Dynamic ModelPradas, R. / Gil de Miguel, A. / Alvaro, A. / Gil-Prieto, R. / Guijarro, P. / Lorente, R. / Antoñ / anzas, F. | 2011
-
PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)Zaitsev, A. / Synopalnikov, A. / Tyrsin, O. | 2011
-
PIN76 Cost Effectiveness analysis of Vaccination with 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in BrazilFujii, R. K. / Mould, J. F. / Presa, J. / Jardim, E. / Sato, R. / Strutton, D. R. | 2011
-
PHP5 Analysis of Linked Medical Claims Data for Preinvestigation in Modeling StudiesEinzinger, P. / Zauner, G. / Popper, N. / Endel, G. / Breitenecker, F. | 2011
-
PHP29 Impact of Different Pharmaceutical Distribution Systems on the Access to Pharmaceutical Products in Six European CountriesWalter, E. / Dragosits, A. / Said, M. | 2011
-
PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis with the RAMQ DatabaseLachaine, J. / Beauchemin, C. / Barbeau, M. | 2011
-
PIN112 Use of Dynamic Models to Measure Health Outcomes of Pneumococcal Vaccination in Spanish Adult PopulationPradas, R. / Guijarro, P. / de Salas-Cansado, M. / Lorente, R. / Antoñ / anzas, F. | 2011
-
PHP109 Tendering of Biosimilars in the UK – Does Launch Price Actually Matter?Viejo Viejo, I. | 2011
-
PIN85 Costs of Influenza and Influenza Like Illness from the Employer's Perspective in PolandKawecka, K. / Wrona, W. / Hermanowski, T. | 2011
-
PSY52 Impact of Two Different Treatment Approaches on Epidemiology of inhibitor Hemophilia in RussiaVorobyev, P. A. / Borisenko, O. / Krasnova, L. / Zhulyov, Y. / Bezmelnitsyna, L. | 2011
-
PMS12 A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in ItalyIannazzo, S. / Didoni, G. / Crocchiolo, D. | 2011
-
PND23 Cost of the Informal Care of Multiple Sclerosis in SpainGubieras, L. / Casado, V. / Romero-Pinel, L. / Matas, E. / Bau, L. / Martí / nez-Yé / lamos, S. / Arbizu, T. | 2011
-
PUK1 Belatacept Versus Tacrolimus: Results of an Indirect Analysis from a Systematic Review of Immunosuppressive Therapies for Kidney Transplant RecipientsSidhu, M. / Odeyemi, A. O. / Hart, W. M. / Dada, B. R. | 2011
-
PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care SettingPala, M. / Sahin, U. | 2011
-
PHP19 Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition in the OECD?Varol, N. / Costa-i-Font, J. / McGuire, A. J. | 2011
-
PMH9 Prescribing Patterns and Cost of Drugs for Alzheimer's DiseaseTruter, I. | 2011
-
PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing SpondylitisUbago, R. / Castillo, M. A. / Marí / n, R. / Flores, S. / Rodrí / guez, R. | 2011
-
PCV131 Cardiovascular Drug Utilization in Relation to Age in Nis RegionKodela, B. / Aleksić / G. / Milić / ević / Velič / ković / R. | 2011
-
PCN201 Cost-Effectiveness Literature on Cancer Therapies, Trends and the Influence of Industry Involvement on OutcomesAl-Badriyeh, D. / Al-Okka, R. / Al-Ameri, M. | 2011
-
PDB16 First Results of the Post-Marketing Survey of Vildagliptin in FranceAttali, C. / Bringer, J. / Simon, D. / Eschwè / ge, E. / Deschaseaux, C. / Dejager, S. / Quere, S. / Bouee, S. / Detournay, B. | 2011
-
PIH43 Changes in Health-Related Behaviours and their Impact on Academic Achievement and Health-Related Quality of Life (HRQOL) Among Spanish AdolescentsRajmil, L. / Ló / pez-Aguilà / S. / Palacio-Vieira, J. A. / Alonso, J. | 2011
-
PRM26 A Literature Review of Methods Used to Estimate Mean Preference-Based Utilities for Comorbidities Using Published Summary StatisticsAra, R. / Wailoo, A. J. | 2011
-
PRM35 Agreement Between Patients' Self-Report and Physicians' Prescriptions on Drugs and Vaccine Exposure: The International PGRX Database ExperienceGrimaldi-Bensouda, L. / Rossignol, M. / Aubrun, E. / Benichou, J. / Abenhaim, L. | 2011
-
PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation ProgramDemarteau, N. / Gomez, J. A. / Lorenzato, F. / Standaert, B. | 2011
-
PCV31 Cerebral Hemorrhage and Transient Ischemic Attack Affected by Meteorological FactorsKriszbacher, I. / Boncz, I. / Szalai, M. / Sebestyé / n, A. / Szili, R. / Kornya, L. / Radnai, Z. / Csoboth, I. | 2011
-
PCV36 High Dose and Long-Term Safety of Systemic Corticosteroids in the Treatment of Polymylagia Rheumatica and Vasculitis: A Systematic ReviewNyssen, O. P. / Gauthier, A. / Schmitt, C. / Levy, V. / Cognet, M. / Aguiar-ibanez, R. | 2011
-
PCV40 Budget Impact Model After the Introduction of Vernakalant in SpainNocea Pulfer, G. / Caloto Gonzalez, M. T. / Martí / n Martinez, A. | 2011
-
PCN144 Health-Related Quality of Life in Prostate Cancer – One Year Follow-up and Comparison with General Population NormsRoine, R. / Bergius, S. / Fä / rkkilä / N. / Muhonen, T. / Rä / sä / nen, P. / Sintonen, H. et al. | 2011
-
PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFAMedina Gó / mez, J. L. | 2011
-
HG4 The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Theoretical Framework and ApplicationEspinoza, M. / Manca, A. / Claxton, K. / Sculpher, M. J. | 2011
-
PMS55 Persistence to Osteoporosis Treatment and its association to the Risk of Fracture Among Women in TaiwanLing, Y. L. / Tang, C. H. / Huang, K. C. / Chang, W. L. | 2011
-
PND27 Economic Analysis of Cost Per Episode of Care for Arm Spasticity and Cervical Dystonia: Comparison of Two Botulinum Toxin A Preparations in 20 CountriesRoze, S. / Marty, R. / Kurth, H. / Godard, A. | 2011
-
PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis StudyBurge, R. / Ionnadis, G. / Adachi, J. / Papadimitropoulos, M. | 2011
-
PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United StatesLevy, A. / Briggs, A. / Johnston, K. / Schnitzler, M. / Litalien, G. J. / Yuan, Y. / Kasiske, B. | 2011
-
PHP69 Can We Increase Hospital Revenue with Different Neuromuscular Blockers? An Analysis of Saving Cost for Hospital Budget with Time Saving Effect of Different Neuromuscular Blockers in Short OperationsKockaya, G. / Daylan Kockaya, P. / Wertheimer, A. / Ozbagrý / acý / k, O. / Oba, S. | 2011
-
PHP72 Evidence-Based Priority Setting for the National Health Development Plan of ThailandPatcharanarumol, W. / Bundhamcharoen, K. / Poungkantha, W. / Prakongsai, P. / Tangcharoensathien, V. | 2011
-
PMS64 Sensitivity of Pro'S to Detect Changes in Quality of Life in Patients Treated with a Biologic AgentPumford, N. / Wade, A. / Crawford, G. / Mcconnachie, A. | 2011
-
PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) TreatmentZerda, I. / Drozdz, A. / Brzyski, D. / Pochopien, M. / Gwiosda, B. / Lisiecka, B. / Barlog, D. / Glogowski, C. / Dziurda, D. / Rys, P. | 2011
-
PIN57 Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in UgandaKuznik, A. / Lamorde, M. / Semeere, A. / Castelnuovo, B. / Hermans, S. / Auerbach, B. / Ssewankambo, F. / Ssennono, M. / Sempa, J. / Mpanga Sebuyira, L. | 2011
-
PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United KingdomHart, W. M. / Munro, V. / Retsa, P. | 2011
-
PHP10 Two Phases Study on the Perspective of Health Care Professionals on Current Mechanisms for Authorizing the Prescription of Specifically Controlled Medicines in SpainOrozco, D. / Basora Gallisa, J. / Garcia, L. / Paz, S. / Lizan, L. | 2011
-
PHP36 Perceptions of Policy Makers and Science Advice Body Staff on Science Advice in Health in EuropeConde Espejo, P. / Palma Ruiz, M. / Sarria-Santamera, A. / Segovia, C. | 2011
-
PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus: Evidence from a Dutch CohortHeintjes, E. / Penning-van Beest, F. J. / Parasuraman, S. V. / Grandy, S. / Pollack, M. / Herings, R. M. | 2011
-
PGI12 Gastroesophageal Reflux Disease Patients Who Switched from a Branded Proton Pump Inhibitor to a Generic One and Vice Versa: A Cost ComparisonXie, L. / Baser, E. / Wang, L. / Baser, O. | 2011
-
PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in IranSoleymani, F. / Farshchi, A. / Haerizadeh, M. | 2011
-
PDB32 Cost of Diabetes and its Complications in Poland: Preliminary ResultsLesniowska, J. / Skrzekowska-Baran, I. | 2011
-
PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)Hutchings, A. / Tolley, K. / Achana, F. / Brereton, N. J. / Lebmeier, M. / Mesa, O. A. | 2011
-
PCN16 Disease Burden and Treatment outcomes in Second-Line Therapy of Patients with Estrogen-Receptor Positive (ER+) Advanced Breast Cancer: A Review of the LiteratureBoswell, K. A. / Wang, X. / Shah, M. V. / Aapro, M. S. | 2011
-
PDB56 Development of a New Measure for Assessing Health Related Quality of Life (HRQOL) in Patients with Primary Hyperparathyroidism (PHPQoL)Farrerons, J. / Muñ / oz, M. / Puig, M. / Villabona, C. / Webb, S. / Badia, X. | 2011
-
PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic ChemotherapySchwartzberg, L. / Jackson, J. / Jain, G. / Balu, S. | 2011
-
PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCCBenkovic, V. / Jelec, D. / Antolic, S. / Stevanovic, R. | 2011
-
PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil: Cost analysis Based on Real World DataClark, O. / Clark, L. G. / Botrel, T. E. / Rosa, B. / Medina, P. / Paladini, L. / Fiol, E. / Rodrigues, N. / Faleiros, E. / Castro, A. P. | 2011
-
PCN46 Cost of Metastatic Prostate Cancer Treatment in the 12 Months Following Diagnosis per Patient in Russian FederationYagudina, R. / Kulikov, A. / Kogon, L. | 2011
-
PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in SpainGarcí / a-Jurado, L. / Morano, R. / Torné / A. / Malvar, A. / Bayas, J. M. / Casado, M. A. | 2011
-
PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer: Comparing the Three Schemes Standards: FOLFOX-4, FLOX and XELOXCalderillo, G. / Melchor, J. / Ruiz, E. / Meneses, A. / Albarran, A. | 2011
-
PRS55 Further Developments of the Living with Chronic Obstructive Pulmonary Disease (LCOPD)Crawford, S. R. / McKenna, S. / Twiss, J. / Oprandi, N. C. / Tammaru, M. | 2011
-
PSS9 The Burden of Age-related Macular Degeneration in the NetherlandsBoland, M. R. / Vingerling, J. / Groot, M. / Hakkaart-van Roijen, L. | 2011
-
VA2 Cost Effectiveness Analysis of Vaccination Programs With 10-Valent (PCV10) and 13-Valent (PCV13) Pneumococcal Vaccines in Bogotá, ColombiaTorres, C. / Jaramillo, J. / Coronell, W. / Gutierrez, M. V. / Caceres, H. A. | 2011
-
PMH3 Cost-Effectiveness Of Paliperidone Palmitate For The Treatment Of Schizophrenia In MÉxicoReyes-Lopez, A. / Querol, J. | 2011
-
PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System PerspectiveSchiola, A. / Silva, A. P. / Santoni, N. B. / Paladini, L. / Teich, V. / Pepe, C. / Rocha, M. M. | 2011
-
PHP17 Mexico'S National and Institutional Essential Medicine ListsRivas, R. | 2011
-
PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, GhanaAgyei-Baffour, P. / Boateng, K. / Nakua, E. / Otupiri, E. / Owusu-Dabo, E. | 2011
-
PSY5 Estudio Costo-Efectividad Del Parche De LidocaÍna Como Terapia Adyuvante A Pregabalina Y Gabapentina En El Manejo Del Dolor NEUROPÁtico PERIFÉrico En El Hospital San José De Bogotá D.C. Enero-Diciembre 2010Hinestrosa, F. / Garzon, L. | 2011
-
PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer PatientsGamper, E. M. / Giesinger, J. M. / Oberguggenberger, A. / Wintner, L. / Singer, S. / Buxbaum, S. / Waitz, D. / Putzer, D. / Nilica, B. / Virgolini, I. | 2011
-
PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms?Armstrong, K. / Handorf, E. / Chen, J. / Bristol-Demeter, M. | 2011
-
PRS5 Analysis Of Efficacy and Safety of Dornase Alfa in The Treatment of Cystic FibrosisKaczor, M. / Wojcik, R. / Rolka, M. / Banas, P. / Niewiara, L. / Kaczynski, L. / Russel-Szymczyk, M. / Szkultecka-Debek, M. | 2011
-
PRS7 Efficacy and Safety of Sildenafil Above 60 mg Daily in Pulmonary Arterial Hypertension Treatment - a Systematic Literature ReviewCukier, F. N. / Fernandes, R. A. / Takemoto, M. L. / Takemoto, M. M. / Fujii, R. K. / Mould, J. F. | 2011
-
PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent CorticosteroidsCortesi, P. A. / Scalone, L. / De Pità / O. / Angelini, G. / Cristaudo, A. / Girolomoni, G. / Gola, M. / Ayala, F. / Cannavò et al. | 2011
-
PRS24 Impact Of Age and Patient Co-Morbidities on Community Acquired Pneumonia (CAP) Related Costs at the Hospital Setting in a Well Defined Area Of Barcelona (Badalona, Spain)Sicras-Mainar, A. / Guijarro, P. / de Salas-Cansado, M. / Cifuentes-Otero, I. / Navarro-Artieda, R. | 2011
-
PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branch Retinal Vein OcclusionAlmond, C. / Hayward, E. / Freemantle, N. / Brereton, N. J. | 2011
-
PMH57 Association of Antidepressant-Related Weight Gain with Degree of Enjoyment and Satisfaction Regarding General Daily Activities, Medication and Overall Quality of LifeSchneider, G. / Roy, A. / Dabbous, O. H. | 2011
-
PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in PortugalDiamantopoulos, A. / Andrade, S. / Bernardo, A. / Branco, J. / Inê / s, L. / Pereira da Silva, J. A. / Santos, M. J. / Monteiro, I. | 2011
-
PMH81 Cost-Effectiveness Analysis of Antidepressants by the IQWIG in GermanyAkmaz, B. / Kessel-Steffen, M. / Friede, M. / Weidenauer, H. / Flü / renbrock, W. | 2011
-
PHP127 Impact of Patient Access Schemes on NICE and SMC GuidanceCooke, C. L. | 2011
-
PRS52 Inpatient Hospital Care or Hospital-At-Home for COPD Exacerbations: A Discrete Choice ExperimentGoossens, L. / Rutten-Van Mö / lken, M. | 2011
-
PRS66 Drug Use Review in Patients with Bronchial Asthma - the Introduction of the Optimization Program of TherapyOskina, E. | 2011
-
CN4 Evaluacion De Costos Del Tratamiento De Primera Linea Para Cancer Colorrectal Metastasico (Mcrc) Con Esquemas Basados En: Folfiri, Folfox O Xelox Mas Bevacizumab, En Cinco Instituciones MexicanasRuiz, G. C. | 2011
-
PCV26 Real World Add-On and Switch Patterns for Platelet Aggregation InhibitorsLö / froth, E. / Bruce, S. / Myré / n, K. J. | 2011
-
PND53 The Patient-Reported Burden of Impaired Walking in Multiple SclerosisMoorcroft, E. / Kennedy, K. / Miller, D. W. / White, J. / Sidovar, M. | 2011
-
PUK2 Comparative Effectiveness of Investigational Compound Ferumoxytol for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease: Systematic Review and Mixed Treatment ComparisonStradwick, S. / Hartmann, J. / Morgan, A. / Freemantle, N. | 2011